SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-032568
Filing Date
2017-05-15
Accepted
2017-05-15 08:08:02
Documents
9
Period of Report
2017-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-12172_88k.htm 8-K 39176
2 EX-4.1 a17-12172_8ex4d1.htm EX-4.1 448256
3 EX-4.2 a17-12172_8ex4d2.htm EX-4.2 708618
4 GRAPHIC g121728ki13i001.jpg GRAPHIC 1709
5 GRAPHIC g121728ki13i002.jpg GRAPHIC 2060
6 GRAPHIC g121728ki13i003.jpg GRAPHIC 2125
7 GRAPHIC g121728ki13i004.jpg GRAPHIC 2302
8 GRAPHIC g121728ki15i001.jpg GRAPHIC 1969
9 GRAPHIC g121728ki15i002.jpg GRAPHIC 2665
  Complete submission text file 0001104659-17-032568.txt   1216006
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 17841177
SIC: 2834 Pharmaceutical Preparations